Compare Indoco Remedies with Mic Electronics - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs MIC ELECTRONICS - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

MIC ELECTRONICS 
   Change

Incorporated in 1986, MIC Electronics is a Hyderabad based company whose business revolves mainly around LED (light emitting diode) and LED based products. The company broadly has two segments media, and informatics and communications (ICT). The form... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES MIC ELECTRONICS INDOCO REMEDIES/
MIC ELECTRONICS
 
P/E (TTM) x 49.8 -0.3 - View Chart
P/BV x 2.0 - - View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 INDOCO REMEDIES   MIC ELECTRONICS
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
MIC ELECTRONICS
Mar-18
INDOCO REMEDIES/
MIC ELECTRONICS
5-Yr Chart
Click to enlarge
High Rs31716 1,983.8%   
Low Rs1784 4,047.7%   
Sales per share (Unadj.) Rs113.17.5 1,516.9%  
Earnings per share (Unadj.) Rs4.5-8.7 -51.4%  
Cash flow per share (Unadj.) Rs11.8-8.3 -141.7%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs73.2-3.5 -2,085.7%  
Shares outstanding (eoy) m92.15220.25 41.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.21.4 160.1%   
Avg P/E ratio x55.5-1.2 -4,724.6%  
P/CF ratio (eoy) x21.0-1.2 -1,713.9%  
Price / Book Value ratio x3.4-2.9 -116.5%  
Dividend payout %22.40-   
Avg Mkt Cap Rs m22,8302,247 1,016.2%   
No. of employees `0005.50.2 3,474.5%   
Total wages/salary Rs m2,20957 3,909.9%   
Avg. sales/employee Rs Th1,910.110,456.7 18.3%   
Avg. wages/employee Rs Th405.0359.9 112.5%   
Avg. net profit/employee Rs Th75.5-12,188.5 -0.6%   
INCOME DATA
Net Sales Rs m10,4191,642 634.7%  
Other income Rs m4712 400.9%   
Total revenues Rs m10,4661,653 633.0%   
Gross profit Rs m1,349-2,202 -61.3%  
Depreciation Rs m67778 873.7%   
Interest Rs m235244 96.3%   
Profit before tax Rs m484-2,512 -19.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m72-599 -12.1%   
Profit after tax Rs m412-1,914 -21.5%  
Gross profit margin %12.9-134.1 -9.7%  
Effective tax rate %15.023.8 62.8%   
Net profit margin %4.0-116.6 -3.4%  
BALANCE SHEET DATA
Current assets Rs m5,373899 597.7%   
Current liabilities Rs m4,1572,754 151.0%   
Net working cap to sales %11.7-113.0 -10.3%  
Current ratio x1.30.3 395.9%  
Inventory Days Days68112 60.3%  
Debtors Days Days7375 97.0%  
Net fixed assets Rs m6,244916 681.5%   
Share capital Rs m184441 41.8%   
"Free" reserves Rs m6,566-1,214 -540.8%   
Net worth Rs m6,750-774 -872.6%   
Long term debt Rs m1,2330-   
Total assets Rs m12,3632,002 617.5%  
Interest coverage x3.1-9.3 -32.9%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.80.8 102.8%   
Return on assets %5.2-83.4 -6.3%  
Return on equity %6.1247.4 2.5%  
Return on capital %9.0293.2 3.1%  
Exports to sales %00-   
Imports to sales %01.3 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA22 0.0%   
Fx inflow Rs m3,7620 5,374,714.3%   
Fx outflow Rs m1,14323 4,924.2%   
Net fx Rs m2,619-23 -11,312.7%   
CASH FLOW
From Operations Rs m1,227329 373.0%  
From Investments Rs m-1,360-1 226,683.3%  
From Financial Activity Rs m-388-330 117.7%  
Net Cashflow Rs m-521-1 43,383.3%  

Share Holding

Indian Promoters % 59.2 8.0 740.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 0.0 -  
FIIs % 6.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 91.2 24.6%  
Shareholders   12,805 43,926 29.2%  
Pledged promoter(s) holding % 0.0 54.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   MOTILAL OSWAL  FINOLEX INDUSTRIES  BAJAJ FINANCE  STC INDIA  TIL  



Today's Market

Sensex Trades Flat; L&T and Tech Mahindra Top Losers(12:30 pm)

Share markets in India are presently trading on a volatile note. Sectoral indices are trading mixed with stocks in the capital goods sector and realty sector.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Nov 13, 2019 02:53 PM

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - NALWA SONS INV COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS